Researchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesized a small molecule that could be a more accessible and effective alternative to an antibody that is successfully used to treat a range of cancers.
Researchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesised a small molecule that could be a more accessible and effective alternative to an antibody that is successfully used to treat a range of cancers. Behind the groundbreaking development is an international team of researchers led by Prof. Ronit Sachi-Fainaro,…
A collaborative research team has synthesized a molecule that could be used as an alternative to the antibodies used in immunotherapy treatment for cancer. The study is published in the <i>Journal for ImmunoTherapy of Cancer</i>.